Abdul, Temilola Y.
Hawse, Gresin P.
Smith, Jay
Sellon, Jacob L.
Abdel, Matthew P.
Wells, James W.
Coenen, Michael J.
Evans, Christopher H. http://orcid.org/0000-0001-5532-2347
De La Vega, Rodolfo E.
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-16-1-0540)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (T32 - 5T32GM00868F20)
Article History
Received: 20 September 2021
Revised: 15 February 2022
Accepted: 18 February 2022
First Online: 9 March 2022
Competing interests
: CHE is a co-founder of Genascence Inc., which is running a Phase I clinical trial in this area (ClinicalTrials.gov Identifier: NCT02790723).
: Mayo Clinic Institutional Review Board approval (IRB# 16-009183).